Patent ID: 7932261

Claim:
A compound of formula (I) wherein is a single or double bond; X is —N—; Q is ═C(R 4 )—; wherein R 4 is selected from the group consisting of hydrogen, halogen, C 1-4 alkyl and C 1-4 alkoxy; R 1 is selected from the group consisting of hydrogen, C 1-8 alkyl, hydroxy substituted C 2-8 alkyl, NR A R B substituted —C 2-8 alkyl, —C 1-4 alkyl-O—C 1-4 alkyl, cycloalkyl, heterocycloalkyl, —(C 1-4 alkyl)-(cycloalkyl) and —(C 1-4 alkyl)- heterocycloalkyl); wherein R A and R B are each independently selected from the group consisting of hydrogen and C 1-4 alkyl; provided that when R 1 is hydroxy substituted C 2-8 alkyl or NR A R B substituted C 2-8 alkyl, then the hydroxy or NR A R B group is not bound to the alpha carbon; A 1 is selected from the group consisting of —C 1-6 alkyl- and —C 2-6 alkenyl-; Y is selected from the group consisting of —N(R 3 )—, —C(O)—N(R 3 )— and —N(R 3 )—C(O)—; provided that when X is ═C— and Q is —C(R 4 )═, then Y is selected from the group consisting of —C(O)—N(R 3 )—; wherein R 3 is selected from the group consisting of hydrogen, C 1-8 alkyl, —C 1-4 alkyl-OH, C 3-8 cycloalkyl, —(C 1-5 alkyl)-C 3-8 cycloalkyl and 5 to 6 membered heterocycloalkyl; wherein the cycloalkyl or heterocycloalkyl is optionally substituted with one or more substituents independently selected from the group consisting of hydroxy, carboxy and —C(O)O—C 1-4 alkyl; A 2 is a absent or is selected from the group consisting of —C 1-6 alkyl-, —C 2-6 alkenyl- and —C 1-6 alkyl-O—; R 2 is -phenyl; Z is —O—; or a pharmaceutically acceptable salt thereof.